Abstract Personalized Genomics companies (PG; also called 'Direct-to-Consumer Genetics') are businesses marketing genetic testing to consumers over the Internet. While much has been written about these new businesses, little attention has been given to their roles in science communication. This paper provides an analysis of the gene concept presented to customers and the relation between the information given and the science behind PG. Two quite different gene concepts are present in company rhetoric, but only one features in the science. To explain this, we must appreciate the delicate tension between PG, academic science, public expectation, and market forces.
1

1.0Introduction
The concept of the gene has a long and multifarious history. It has been pronounced 'dead' (Gray 1992) only to be later revived (Neumann-Held 1999) , heralded as the hallmarkscientificconceptofthe20 th century(FoxKeller2000),thendeclaredobsolete inlightofmoreprecisebiologicaltaxonomy(Fogel2000),allthewhilebeingredefined countless times for countless purposes. In spite of this controversy, the gene has not disappeared from view. Spurring and capitalizing on the public fascination with genetics, a new type of commercial enterprise has recently arisen offering genetic testingdirectlytoconsumers.SeveralsuchInternet-basedcompaniesarenowthriving.
These Personalized Genomics companies (sometimes called 'Direct-to-Consumer Genetics'or'RetailGenetics')havearousedagreatdealofattentionfromgovernments rushing to erect regulations, from journalists sensationalizing scientific advancements, and,perhapsmostimportantly,fromconsumerseagertopartakeinthegainsofmodern science.Amidallofthisexcitement,itisimportanttopauseforamomentandexamine the concept that is central to Personalized Genomics (PG). I believe it is prudent to determinewhat,precisely,the'gene'inPersonalizedGenomicsreallyisandwhatitcan purportedlydo.
Scientific concepts in commercialized science are an important topic. These concepts are powerful and their effects are wide-reaching. For many, popular culture and the media have long been the only sources of education about molecular biology and genetics (Bates 2005 ). Yet information from these sources is rarely in-depth, and has been hotly criticized (Kua et al 2004) . PG is a new source of information about genetics,onewhichcustomersmayviewasmorereliablethanothersources(compare Bates 2005 and Kaufmann 2012) . It is therefore prudent to determine what sorts of knowledgeaboutgenesandgeneticsthepublicisliabletoreceivefromPG.Studieshave already shown that most customers view PG as a source of knowledge about disease (McGuire et al. 2009 ) and that many intend to use knowledge gained to inform health decisions (Kaufmann 2012) . Though customers report a high-degree of confidence in their understanding of PG science, that confidence may be misplaced. Leighton and colleagues(2012) reportthatcustomers'frequentlymisinterpretPGresultsinspiteof self-assessments to the contrary. This is worrying when we consider that over 1/3 of prospectivecustomersexpectresultstobeequivalenttomedicaldiagnoses (McGuireet al.2009 ).
Customers' poor comprehension of PG science has been attributed to both the extremelyhighliteracydemandsofPGwebsites(Lachanceetal.2010)andthepublic's generally poor understanding of statistics (Leighton et al. 2012) . I suggest that examining the concept of the gene will shed new light on the nature of this problem.
Further, misapprehension the science, via misunderstanding of the gene, is a problem thatextendsbeyondthescopeofPGteststhemselves.Knowledgeofgeneticswillgoon toinformfuturedecisionsaboutandassessmentsofgeneticandbiologicalclaims.Lay conceptionsofgeneticcausationhaveimplicationsfortopicsfromracismandprejudice (Condit 2011; Bates 2005) , to more everyday topics like fairness in sport (eg. see exchangeinCohen2008).Beyondthesepracticalimplications,epistemicconsequences are a virtual certainty as false beliefs about genetics form the basis for yet further misunderstanding.Evaluatingthequalityofinformationonofferisthereforeimportant forbothcustomers'understandingofPGteststhemselves,andfortheirunderstanding ofscience,moregenerally.
2.0PersonalizedGenomics
Although there are a number of types of business to which 'Personalized Genomics' might refer, I will focus only on one such business model here. These are 'complete' genome scans, so-called because they assess large samples of DNA from across the genomeandforwardpredictionsaboutawiderangeoftraits.Ihavechosentofocuson threecompaniesasrepresentativeofthisclass:Navigenics,23andMe,anddeCODEme.
2.1THESCIENCEBEHINDPERSONALIZEDGENOMICS
Personalized Genomics companies operate almost exclusively online. (1) 0.77%
(2) 1.3 (3) 1.001%
That means that~10 of 1000 males of European descent with this risk allele will developColitis.
1 It is interesting that PG companies use the number of SNPs included in their tests as marketing tools.
Some boast of using 2 million where others used only 1.5. Since only a few thousand of those SNPs confer any information, the gross amount of SNPs tested is little indication of test quality. 2 Some companies omit (2), requiring you to infer the subjective risk, or omit (3), requiring you to calculate adjusted risk. 3 There are some interesting and important questions about the degree to which this is accomplished.
Many ethnic groups are not represented in the GWAS studies on which PG results are based. See (Mountain et al., 2007) . (Hunter, Khoury et al. 2008) . Though it may be interesting to know thatyoucarryamarginalincreaseinriskforsometraitorcondition,thepracticalvalue of that information is often quite small. John P. Ioannidis, one of the most widely publishedcommentatorsonGWAS,notesthatmanypeoplemaybeunawareofthelow clinicalutilityofthesepredictions,
[T]he utility of the genetic tests rests on the brittle assumption that there is a very specific and noncontestable risk threshold that leads to very different actionplans. (Iaonnidis2009) 4 Perhaps the most discussed of these is height, which is estimated to be 80-90% heritable, but for which SNPs account for only 5%. The issue of missing heritability is a complex one. The poor risk associations discussed here are but a symptom of this greater problem. On the problem of heritability estimates, see (Sesardic 2005) . On the problem of missing heritability, see (Maher, 2008 (Waters,2004) .
customer reports. Whether the gene presented to customers aligns with the gene conceptusedinPGscienceisanopenquestion.
3.1SNPSANDGENES
To determine the gene concept at work in the collection of data, it is best to begin by determining how genes are conceptualized in the context of GWAS, the science that featuresmostprominentlyinPGpractice.
PGcompaniesaresomewhatindiscriminatewithregardtotheselectionofSNPs.
Roughly57%ofthetrait-associatedSNPsidentifiedbyGWASfallwithinprotein-coding
DNA ( In the physician information FAQ section of Navigenics' website there is a clue intothegeneconceptonoffer.UndertheFAQ'IsaSNPthesameasagenemutation?' theresponseis, No,notnecessarily.ASNPmayrepresentapointmutation(meaningaknown disease-causing variant in the genetic code). Individual disease-causing mutations are rare; they occur in less than one percent of the population. However,SNPsusedtoassesscommondiseases…arecommonvariantsfound in more than one percent of the population. SNPs are most often thought of as 'predisposition' genetic markers, not as disease causing genetic markers. 7 (Navigenics2010) This is the closest one gets to an explanation of the SNP-gene relationship within the informationprovidedtophysicians.Thoughitisnotclearpreciselywhattheytakethe relationship between SNPs and genes to be, this resembles the SNP-as-surrogate view commoninthefield.Onaninformationpageabout'GeneticMarkers'wefindaclearer definition:
SNPs may not actually cause the condition, but we know they are either on or closetogenesthatincreasetheriskofthatconditionandarethereforeusedas markersofincreasedpredispositiontothatcondition. 8 (Navigenics2010) A short definition on a terminology sheet identifies 'gene' with a molecular gene account.
Genes are segments of DNA dotted throughout the genome that contain blueprintsforvariousproteins. 9 (Navigenics2010)Takentogether,thisappearstobemuchthesameastheSNP-generelationshipassumed inGWAS.Giventhedifficultyinobtainingthisexplanation,however,itisdoubtfulthat thecustomerwoulddecipherthis. 10 deCODEme is perhaps the least forthcoming about the relationship between SNPsandgenes.Thoughtheir'GeneticsExplained'guideimplicitlyidentifiesgeneswith both chromosomes and the whole genome, and uses 'gene' as an umbrella term for multiplepossibleSNPsatagivenlocus,theyalsoofferanexplicitdefinitionofthegene.
[Genes] are relatively small segments of chromosomes, where the sequence of DNAnucleotidesencodesarecipeformakingaprotein. 11 (deCODEme,2010) TheyalsoexplainwhatisdonewhenaSNPisidentifiedasarisk-allele.
Usually, further research is needed to find out whether this SNP or another nearbyisthetruegeneticcauseofthecharacteristicinquestion. 12 (deCODEme 2010) Again,thisexplanationseemstofitwiththeSNP-generelationshipandmoleculargene conceptionusedinPGscience.
3.2SNPS,GENES,ANDTRAITS
Given this presentation of the SNP-gene relationship, how is the relationship between SNPs, protein-coding genes, and human traits presented? For the answer to this question,Ithinkwecanturnfirstto23andMe.
23andMe provides a "Keywords for Genetics" information sheet, which, like the othercompanies,givesatypicalmoleculargeneaccount.
Each kind of protein tool has its own blueprint, or gene, located in the cell's nucleus. Genes can be turned on or off in different cells at different times. (23andMe2010b) Furtherdownthesheet,wefindthefollowingexplanationofSNPs:
ASNPisasiteinthegenomewhereasingleDNA'letter'oftendiffersfromperson to person. Some (but not all) SNPs appear to be associated with variation in differentpeople'sphenotypes.(23andMe2010b) OntheirownthesedefinitionstelluslittleaboutthemechanismlinkingSNPstotraits; but when we examine the diagram by which they are accompanied, it becomes clear howSNPsaremeanttofit.ThediagramdepictsageneasasectionofDNA,amolecular gene.WithinthatgenefallsaSNP,whereaGuaninenucleotidehasbeensubstitutedfor a Cytosine. That SNP results in the translation of a different protein from the gene, 10 The difficulty in piecing together information about the science will only be compounded by the extremely high reading level required of PG users. Lachance et al (2010) found that the reading level of PG websites was 15, at least 6 grades above the average reading comprehension of US citizens. Atatimewhenfamiliesaregathered,weareremindedthatourfamily'shealth history offers a window into our own health, providing insight on some of the heritablefactorsthatmaypredisposeustoparticularhealthconditions.Family history -particularly gathered through the online platform -is an easy, accessible means by which we all can take greater control over our health. A seeminglysmallstep,familyhistorycouldprovideuswithafoundationonwhich we can collectively build a new era of disease prevention. (Navigenics 2010, November23) This information is all correct. The internet is an excellent means by which to collect familyhistoryinformation,andfamilyhistoryisapowerfultoolfordiseaseprediction.
The latter is precisely why standard clinical practice for assessing many traits and conditions begins with a simple family history; for generations this was the only such metric available. Today, in the midst of genetic testing, family history remains a powerful tool for predicting risk for many diseases from diabetes to various cancers.
There are well-established models of familial risk associations based on heritability patternsthatcanbeusedbycliniciansandpatients.
The utility of family history is no accident. Some of the reasons behind the predictive power of family history are now understood. Of course one reason is that disease-causing nucleotide variants are heritable. But there are other reasons, too.
Many epigenetic disease risk factors, such as methylation patterns, are inherited in predictablefamilialpatterns,asarebehaviours,traditions,diet,andhabitat.Allofthese may confer risks for different diseases and traits. Importantly, much of the risk information conferred by familial assessments is not captured in a SNP-based genetic test. That these three companies so publically endorse the value of knowing one's family history is laudable. What is surprising, however, is that none of these PG companiesincorporatesfamilyhistorydataintothecalculationofriskassessments.Nor areanymechanismsprovidedforcustomerstomaketheseassessmentsthemselves. 17 PGrepeatedlyacknowledgestheimportanceofvariablesfortraitprediction,yet does nothing to incorporate those variables into risk-assessments. An interesting question is whether customers, steeped in PG literature about family history and environment,areawarethatnosuchinformationimpactsthepredictionstheyreceive. 19 This may be set to change, a new company, Personalis, promises to integrate whole-genome scans with clinical risk information (family history, behaviour, etc.). It will be interesting to watch whether, if successful, Personalis prompts other PG companies to follow suit, as I predict.
translating GWAS research into clinical practice, which will yield stronger SNP-trait correlations. Yet it is difficult to reconcile such a belief with their public emphasis on environmentalvariables,anditishardtoimaginethattheyseenobenefitinincluding suchdata.
I think a more plausible explanation, one that highlights the importance of examining commercialized science as distinct from mainstream science, is that these companies have no prerogative or precedent to take environmental data into account.
Increasesinthepredictivepoweroftheirassessmentsarenotbeingdemandedbythe marketanditwouldruncontrarytoPG'sinterestsquabusinesstoimplementanysuch changes. The cost of this, balanced against prospective returns, is simply too high at present for a for-profit enterprise to bear. PG companies are still attracting flocks of customers, they are still receiving attention in the press, and they are still raising impressive amounts of capital from investors (see 23andMe 2011, Jan. 7; Navigenics 
